Novo Nordisk to acquire Germany's Cardior Pharmaceuticals for EUR 1 billion
Novo Nordisk is taking a German biotech company under its wing.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.